| Title |
XDx - Expression Diagnostics
|
| Description |
XDx has applied microarray, real-time PCR (polymerase chain reaction) and bioinformatics technologies to develop a new way to monitor the immune system. The company's first commercial service, AlloMap molecular expression testing is a noninvasive, multi-gene, multi-pathway gene expression test that enables physicians to distinguish rejection from quiescence in heart transplant patients.
|
| Keywords |
[xdx, expression diagnostics, CARGO study, CARGO, immunomap testing, immunomap, auto-immunity, transplant, ivdmia, acute cellular rejection, heart, kleiner perkins, kpcb, tpg, tpg ventures, sprout, burrill, gene expression, molecular diagnostics, brook byers, personalized medicine, human genome project, hgp, immune status, rejection, quiescence]
|
|
